Chronology of Occult and Gross Coagulopathy in Burn Patients
NCT01638481 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 158
Last updated 2022-02-16
Summary
The purpose of the study is to identify the inflammatory and coagulation pathways and mechanisms that are activated immediately following burn injury, and how they affect outcomes in terms of organ failure and death. This study also addresses the limitation of current tests (PT, PTT, and platelet counts) employed to identify coagulation disturbances in severely injured patients both in a comprehensive and rapid manner.
Conditions
- Thermal Burns
Sponsors & Collaborators
-
United States Department of Defense
collaborator FED -
Medstar Health Research Institute
lead OTHER
Principal Investigators
-
Jeffrey Shupp, MD · Medstar Health Research Institute
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-07-31
- Primary Completion
- 2017-03-31
- Completion
- 2021-06-30
Countries
- United States
Study Locations
More Related Trials
-
Significance of Platelet Indices and Ratios in Different Degrees of Burn
NCT06612385 ·Status: NOT_YET_RECRUITING
-
A Multicenter Comparative Study of the ReCell Device and Autologous Split-thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries
NCT01138917 ·Status: COMPLETED ·Phase: NA
-
Surgical Critical Care Initiative (SC2i) Tissue and Data Acquisition Protocol (TDAP) in Burn Patients Improving the Robustness and Generalizability of Post-burn Sepsis Prediction With the Post-Burn Sepsis Digital Twin. Group 1
NCT07249762 ·Status: NOT_YET_RECRUITING
-
Association of Cytokines With the Development of Complications in Burn and Toxic Epidermal Necrolysis (TENS) Patients
NCT04252651 ·Status: UNKNOWN
-
Soluble Factors in the Serum of Severely Burned Patients
NCT02549079 ·Status: COMPLETED
-
Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Burns
NCT03002506 ·Status: TERMINATED ·Phase: PHASE4
-
TDAP in Burn Patients (Group 2)
NCT07223684 ·Status: NOT_YET_RECRUITING
-
HLA Sensitization in Severely Burned Patients
NCT02537821 ·Status: UNKNOWN
-
A Trial of Restrictive Versus Traditional Blood Transfusion Practices in Burn Patients
NCT01079247 ·Status: COMPLETED ·Phase: NA
-
Identification and Validation of Biomarkers for Infections in Burns
NCT02457663 ·Status: TERMINATED
-
Autologous Platelets Concentrate and Autologous Thrombin for the Treatment of Deep Burn Trauma
NCT01383187 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Antimicrobial Resistance of Bacteria in Burn Patients
NCT00794742 ·Status: COMPLETED
-
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
NCT01636362 ·Status: COMPLETED ·Phase: NA
-
Testing an Innovative Biomarker: Expression of HIF-1α and Its Isoforms in the Blood and Skin Tissue of Major Burns
NCT02870439 ·Status: UNKNOWN ·Phase: NA
-
Microsurfaced Grafts in Deep Burn Wounds
NCT04589442 ·Status: RECRUITING ·Phase: PHASE4
-
Using Autologous Platelet Rich Plasma (PRP) Gel to Treat Deep 2nd and 3rd Degree Burns
NCT01843686 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Assessment of Protopic® Ointment in Deep Partial-Thickness Burns
NCT05856994 ·Status: RECRUITING ·Phase: PHASE1
-
Microbiome Changes in Severe Burns
NCT03130868 ·Status: COMPLETED
-
Efficacy of a Fibrin Sealant in Burn Surgery
NCT00181974 ·Status: COMPLETED ·Phase: NA
-
Adult Stem Cell Response to Burn Injury
NCT00609661 ·Status: WITHDRAWN
-
Albumin Use in Burn Patients
NCT00609414 ·Status: COMPLETED
-
Research on the Key Technology of Burn Wound Treatment
NCT03279549 ·Status: UNKNOWN ·Phase: NA
-
Hemofiltration in Burns: RESCUE (Randomized Controlled Evaluation of Hemofiltration in Adult Burn Patients With Septic Shock and Acute Renal Failure)
NCT01213914 ·Status: UNKNOWN ·Phase: NA
-
Keratinocyte Growth Factor and Cytokines in Burns.
NCT01302223 ·Status: COMPLETED
-
Effectiveness of KeraStat Gel for Improved Cosmesis of Partial Thickness Burns
NCT03564795 ·Status: TERMINATED ·Phase: NA